Physician profile
Melissa A Shute
NPI 1104283597
$3,599.22
in general payments reported to CMS, 2019-2025
11 companies · $260 in 2025
The $260 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $722 · 2022: $158 · 2023: $2,077 · 2024: $382 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,566 · Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,566.11 |
| Food and Beverage | $1,153.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,028.09 | 2021-2023 | |
| Abbott Laboratories | $835.86 | 2021-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Gallant |
| Boston Scientific Corporation | $170.69 | 2021-2024 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $150.84 | 2022-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $137.27 | 2021 | |
| Pfizer INC. | $105.42 | 2023-2025 | |
| Altathera Pharmaceuticals LLC | $90.79 | 2022-2023 | Sotalol Hydrochloride |
| E.R. Squibb & Sons, L.L.C. | $33.31 | 2023-2024 | Camzyos |
| Watermark Medical, INC. | $17.68 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $15.37 | 2023 | Farxiga |
| Amarin Pharma, INC. | $13.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Shute listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.